Phase 1b Trial of Pembrolizumab Monotherapy for Relapsed/Refractory Multiple Myeloma: KEYNOTE ‐013
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15888
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2019
Authors
Publisher
Wiley